Tracking lung health after stem cell transplant
Part of Blood & lymphatic, Immune system & allergy, Lungs & breathing clinical trials.
This study follows people getting a stem cell transplant to watch for lung problems, like infections or other lung diseases, that can happen after the transplant. The goal is to catch these issues early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 5 and 70 years old
- You are scheduled to get a stem cell transplant (from a donor) for a blood cancer or a blood/immune system disorder at the NIH
- You are willing to follow the study plan and be available for the whole time
- You are not pregnant or breastfeeding
- You (or your guardian) understand the study and can sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients who have received a stem cell transplant from a donor to track and understand fungal infections that can occur afterward. By studying this carefully, researchers hope to better prevent and treat these serious infections in future patients.
This study looks at how often liver problems happen and how they develop in people being evaluated for a stem cell transplant. It may help doctors predict and better manage liver complications during and after transplant care.
This study looks at how your body processes medications after a stem cell transplant from a donor. It aims to find the best way to test your genes to improve future treatments.
This study checks how people do long-term after stem cell transplant, cellular therapy, or gene therapy. It may help doctors track longer-term health effects and recovery and improve future care.
This trial tests whether adding back certain immune cells after a stem cell transplant can help prevent serious viral or fungal infections. It's for children and young adults up to age 25 who need a transplant for a blood cancer or other curable disease.
This study follows children and teens who get a stem cell transplant to learn how lung problems develop over time. Your participation could help doctors better predict, prevent, and manage lung injury after transplant.
Hear when a new Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.